Bio-Techne Corp

Bio-Techne Corp


Market Cap$11.96B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bio-Techne CorpBio-Techne Corp58.90.42%-10.8-

Current Fair Value

46.4% downside

Overvalued by 46.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$11.96 Billion
Enterprise Value-
Dividend Yield$0.3189 (0.42%)
Earnings per Share$1.26
Outstanding Shares157,584,637
Avg 30 Day Volume1,122,292


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio58.94
Price to Sales10.78
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Bio-Techne Corp

2,100 employees
CEO: Charles Kummeth

Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...